QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.105.012005v1 68/4/974    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dunlop, J. Articles by Butera, J. Search for Related Content PubMed PubMed Citation Articles by Dunlop, J. Articles by Butera, J.

Characterization of Novel Aryl-Ether, Biaryl, and Fluorene Aspartic Acid and Diaminopropionic Acid Analogs as Potent Inhibitors of the High-Affinity Glutamate Transporter EAAT2

Discovery Neuroscience (J.D., H.B.M., T.A.C., B.J., Q.L., D.K., S.L.) and Chemical & Screening Sciences (A.G., C.G., K.F., J.B.), Wyeth Research, Princeton, New Jersey; and Neurocrine Biosciences, San Diego, California (R.P., J.W., A.F.)

In this study, we describe the pharmacological characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of EAAT2, the predominant glutamate transporter in forebrain regions. The rank order of potency determined for the inhibition of human EAAT2 was N⁴-[4-(2-bromo-4,5-difluorophenoxy)phenyl]-L-asparagine (WAY-213613) (IC₅₀ = 85 ± 5 nM) > N⁴-(2'-methyl-1,1'-biphenyl-4-yl)-L-asparagine (WAY-213394) (IC₅₀ = 145 ± 22 nM) = N⁴-[7-(trifluoromethyl)-9H-fluoren-2-yl]-L-asparagine (WAY-212922) (IC₅₀ = 157 ± 11 nM) = 3-{[(4'-chloro-2-methyl-1,1'-biphenyl-4-yl)carbonyl]amino}-L-alanine (WAY-211686) (IC₅₀ = 190 ± 10 nM). WAY-213613 was the most selective of the compounds examined, with IC₅₀ values for inhibition of EAAT1 and EAAT3 of 5 and 3.8 µM, respectively, corresponding to a 59- and 45-fold selectivity toward EAAT2. An identical rank order of potency [WAY-213613 (35 ± 7 nM) > WAY-213394 (92 ± 13 nM) = WAY-212922 (95 ± 8 nM) = WAY-211686 (101 ± 20 nM)] was observed for the inhibition of glutamate uptake in rat cortical synaptosomes, consistent with the predominant contribution of EAAT2 to this activity. Kinetic studies with each of the compounds in synaptosomes revealed a competitive mechanism of inhibition. All compounds were determined to be nonsubstrates by evaluating both the stimulation of currents in EAAT2-injected oocytes and the heteroexchange of D-[³H]aspartate from cortical synaptosomes. WAY-213613 represents the most potent and selective inhibitor of EAAT2 identified to date. Taken in combination with its selectivity over ionotropic and metabotropic glutamate receptors, this compound represents a potential tool for the further elucidation of EAAT2 function.

Address correspondence to: Dr. John Dunlop, Neuroscience Discovery Research, Wyeth Research, CN 8000, Princeton, NJ 08543. E-mail: dunlopj{at}wyeth.com

This article has been cited by other articles:

				S. Colleoni, A. A. Jensen, E. Landucci, E. Fumagalli, P. Conti, A. Pinto, M. De Amici, D. E. Pellegrini-Giampietro, C. De Micheli, T. Mennini, et al. Neuroprotective Effects of the Novel Glutamate Transporter Inhibitor (-)-3-Hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic Acid, Which Preferentially Inhibits Reverse Transport (Glutamate Release) Compared with Glutamate Reuptake J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 646 - 656. [Abstract] [Full Text] [PDF]

				K. Shimamoto, Y. Otsubo, Y. Shigeri, Y. Yasuda-Kamatani, M. Satoh, S. Kaneko, and T. Nakagawa Characterization of the Tritium-Labeled Analog of L-threo-beta-Benzyloxyaspartate Binding to Glutamate Transporters Mol. Pharmacol., January 1, 2007; 71(1): 294 - 302. [Abstract] [Full Text] [PDF]